metastatic adenocarcinoma Clinical Research Trials | TrialX

Loading...

Please select a valid location from the dropdown

Filter By

Clear all Advanced

Advanced Filters

Gender
Phase
Study Type
Sponsors
Accepts healthy volunteers
Online Trials
Age Group

Any (1)

Phase 2 (1)

Interventional (1)

Blokhin's Russian Cancer Research Center (1)

Yes (1)

No (1)

Adult (18+) (1)

I am/have/had

I am/have/hadgastric adenocarcinoma

I am/have/hadcarcinoma

I am/have/hadcombination chemotherapy

I am/have/hadgastric cancer

I am/have/hadhepatitis b

I am/have/hadmetastatic gastric cancer

I am/have/hadHIV Infection

I am/have/hadneutrophil count

I am/have/hadmetastatic adenocarcinoma

I am/have/hadcancer

I am/have/hadhepatitis

I am/have/hadadenocarcinoma of the gastroesophageal junction

I am/have/hadabsolute neutrophil count

I am/have/hadmodified folfirinox

I am/have/hadgastric carcinoma

I am/have/hadadenocarcinoma

I am/have/hadimmunodeficiency

added new label for I am/have/had

more

I am looking for

I am looking forcombinations

I am looking foririnotecan

I am looking forleucovorin

I am looking forhepatitis b

I am looking foroxaliplatin

I am looking forfluorouracil

added new label for I am looking for

more

Advanced Filters

Loading...

Found 1 clinical trials

We call this “infoimagery”. It is unique to every trial and is generated based on a trials specific data eg. therapeutic area, study type, phase etc. and the centerwatch system associates the information to a matching set of related symbols and icons.

What's this?

FOLFOX6 Versus mFOLFIRINOX as First Line Chemotherapy in Metastatic Gastric Cancer or Esophagogastric Junction Adenocarcinoma (Type II-III)

Patients with metastatic adenocarcinoma of the stomach or the esophagogastric junction (II-III type by Siewert) without previous therapy will be treated with one of two chemotherapy combinations .

combinations

leucovorin

fluorouracil

gastric adenocarcinoma

carcinoma

0 views
19 Feb, 2024

Congrats! You have your own personal workspace now.

Learn more

© Copyright TrialX 2025 All rights reserved.